Can a brief home therapy cut suicide reattempts? new study aims to find out
NCT ID NCT06322199
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a short, home-based therapy called ASSIP Flex for adults who have attempted suicide. The therapy involves 3-4 sessions delivered in the patient's own environment. Researchers will track suicidal thoughts and behaviors over 12 months to see if the therapy is feasible, cost-effective, and helps reduce repeat attempts. The study enrolls 119 participants in Switzerland.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ASSIP Flex (a brief, home-based behavioral therapy for people who have attempted suicide)
What this could lead to
If it works, this could provide an effective, cost-saving way to deliver suicide prevention therapy at home, reducing repeat attempts.
What could go wrong
This is a small feasibility study (119 people) with no control group, so results may not prove effectiveness. The therapy may not work for everyone, and some participants might drop out.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUICIDAL IDEATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center Neuchâtelois de Psychiatrie
Neuchâtel, Switzerland
-
Centre Hospitalier universitaire vaudois (CHUV)
Lausanne, Switzerland
-
Psychiatric Hospital, University of Zurich (PUKZH)
Zurich, Switzerland
-
Sanatorium Kilchberg
Zurich, Switzerland